Ignite Creation Date:
2024-07-17 @ 10:48 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06492317
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-06-30
Brief Title:
RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer
Sponsor:
The First Affiliated Hospital of Zhengzhou University
Organization:
The First Affiliated Hospital of Zhengzhou University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| HER2-positive Gastric Cancer |
Keywords: